The incidence of kidney stone recurrence did not significantly differ among patients who received hydrochlorothiazide compared with those who received placebo, according to a study published in The ...
Hydrochlorothiazide, which for decades has been a standard treatment to prevent the recurrence of calcium-containing kidney stones, did not lower the rate of stone recurrence in the NOSTONE randomized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback